Trends and hotspots in tea and Alzheimer's disease research from 2014 to 2023: A bibliometric and visual analysis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tea consumption shows promise for Alzheimer's disease (AD) treatment. Research highlights its antioxidant and anti-amyloid properties, particularly epigallocatechin gallate, for neuroprotection in AD.
Area Of Science
- Neuroscience
- Pharmacology
- Biochemistry
Background
- Growing interest in tea's positive effects on Alzheimer's disease (AD).
- Lack of comprehensive quantitative analysis on tea and AD research.
- Need for a structured overview of the current research landscape.
Purpose Of The Study
- To analyze the research status and hotspots concerning tea and Alzheimer's disease from 2014 to 2023.
- To provide a valuable reference for future research in this field.
- To identify key trends and influential publications in tea-AD research.
Main Methods
- Bibliometric analysis of 374 documents published between 2014 and 2023.
- Data sourced from the Web of Science database.
- Analysis and visualization performed using R software, VOSviewer, and Citespace.
Main Results
- Consistent annual increase in publications from 2014-2023.
- China, the United States, and India are leading countries in publications.
- Key research areas include oxidative stress, amyloid, epigallocatechin gallate, and green tea polyphenols, focusing on antioxidative and anti-amyloid actions.
Conclusions
- Tea's role in ameliorating AD is a significant research hotspot for future drug development.
- This study offers a comprehensive analysis of the current landscape and hotspots of tea's application in AD.
- Provides an estimable reference for future research endeavors in tea-based Alzheimer's disease interventions.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....